Abstract:Objective:To study the change of dose distribution by the change of the volume and morphology of the tumor and the normal tissues through the process of the nasopharyngeal carcinoma IMRT. Methods:All 42 patients who were pathologically diagnosed as nasopharyngeal carcinoma from January 2009 to June 2010 were admitted. All patients underwent a simulation CT before the treastment,and the images were uploaded to the Xio treatment therapy system( TPS). The target volume and normal tissues were contoured on the CT image and then the treatment IMRT plan was developed using 6MVX,9 coplanar fields. The dose to the nasopharyngeal tumor and lymph node was 66Gy/30f/6w,dose to the nasopharynx subclinical lesions and neck lymphatic drainage area was 60Gy/30f/6w. Daily or-thogonal images were acquired in the patient treatment position to compare with the DRR of the original treatment planning image,and the patient positionning error was corrected in three dimensions,then the radiation therapy was implemented. Each patient underwent a simulation CT scan weekly to analyse the dose distribution changes of the tar-get and the normal tissues. Concurrent chemotherapy regimen was cisplatin plus docetaxel every 3 weeks,the chemo-therapy was started before the beginning of the radiaotherapy. Results:The average volume of GTV1 was 39. 19cc be-fore radiotherapy,GTV2 was 16. 59cc,at 4th and 6th week of the radiotherapy course the average reduction of GTV1 were 26. 41%,62. 68%,for GTV2 were 28. 43%and 53. 93%respectively. Before treatment,the average volume of bi-lateral parotid was 24. 16cc,at 4th week of radiation therapy,the average volume of parotid was 19. 04cc,at 6th week the average volume of the parotid gland was 17. 54cc. For the does distribution to the normal tissues,in the original plan,spinal cord(D1%),brainstem(D1%),temporal lobe(D1%),the inner ear(Dmean),parotid gland(V30)are(41. 2 ± 0. 98)Gy,(51. 26 ± 1. 57)Gy,(59. 95 ± 2. 11)Gy,(45. 02 ± 1. 98)Gy,(47. 87 ± 18. 05)% respectively,at 4th week of radiotherapy,they are(44. 09 ± 1. 88)Gy,(52. 81 ± 2. 47)Gy,(62. 04 ± 2. 43)Gy,(47. 24 ± 3. 68)Gy, (49. 03 ± 15. 68)%,and at 6th week,(44. 44 ± 2. 7)Gy,(54. 14 ± 2. 51)Gy,(62. 34 ± 2. 86)Gy,(48. 37 ± 5. 37) Gy,(52. 19 ± 15. 51)%. Conclusion:In the nasopharyngeal IMRT process,the actual dose distribution of the tumor will be some difference to the original plan,except one case whose outline contour changes relatively sever because of the shrinkage of the lymph node and the weight loss,the CTV actual dose is above 95%of the prescribed dose,al-though after a few weeks of treatment the tumor target volume and shape changes,the difference was not significant. The dose to the normal tissues in the whole course of treatment will be increased compared with the original plan.

Estimation of Radiotherapy Modalities for Patients with Stage I-II Nasal Natural Killer T-Cell Lymphoma

Dosimetric Comparison of Helical Tomotherapy, VMAT, Fixed-Field IMRT and 3D-Conformal Radiotherapy for Stage I-II Nasal Natural Killer T-cell Lymphoma

A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma

Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma

Mild Toxicity and Favorable Prognosis of High–Dose and Extended Involved-Field Intensity-Modulated Radiotherapy for Patients with Early-Stage Nasal NK/T-Cell Lymphoma

Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma

A detailed dosimetric comparative study of IMRT and VMAT in normal brain tissues for nasopharyngeal carcinoma patients treated with radiotherapy

Dosimetric Comparison and Selection Criteria of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy for Adaptive Re-Plan in T3-4 Nasopharynx Cancer Patients

Dosimetric study of TomoDirect technology in radiotherapy for nasopharyngeal carcinoma

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.

Comparison of Dosimetric Benefits of Three Precise Radiotherapy Techniques in Nasopharyngeal Carcinoma Patients Using a Priority-Classified Plan Optimization Model

Dosimetric Comparison of the Helical Tomotherapy, Volumetric-Modulated Arc Therapy and Fixed-Field Intensity-Modulated Radiotherapy for Stage IIB-IIIB Non-Small Cell Lung Cancer

A dosimetric comparison between helical tomotherapy and linear accelerator-based intensity modulated radiation therapy for nasopharyngeal carcinoma

Dosimetry Study to Improve the Method of Organs at Risk(OAR) Delineations and Planning Optimization in Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Toxicity and treatment outcome of intensity-modulated radiation therapy for early stage nasal and Waldeyer ring NK/T-cell lymphoma

Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma (vol 43, pg 140, 2020)

Dose-volume study for tumor and normal tissue of nasopharyngeal carcinoma with IMRT

Specific-CT brain template construction and retrospective dosimetric comparison study in brain for nasopharyngeal carcinoma patients treated with IMRT or VMAT

Impact of Reducing Clinical Target Volume on Efficacy of Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Dosimetric Analysis of Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma

The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.